AQR Arbitrage’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

AQR Arbitrage’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-150,003	Closed	-$1.56M	–	1040
2023 Q1	$1.56M	Sell	150,003 -1,893	-1%	-$19.6K	0.05%	366
2022 Q4	$1.56M	Hold	151,896	–	–	0.04%	445
2022 Q3	$1.53M	Hold	151,896	–	–	0.03%	530
2022 Q2	$1.51M	Hold	151,896	–	–	0.03%	498
2022 Q1	$1.51M	Buy	+151,896	New	+$1.51M	0.04%	422

AQR Arbitrage's LVAC Position: Q2 2023 in Review

AQR Arbitrage sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 150,003 shares — an estimated $1.56M sold.

AQR Arbitrage first reported a position in LVAC in Q1 2022 and held it in 5 quarters. The position peaked at $1.56M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

AQR Arbitrage reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
AQR Arbitrage sold 150,003 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $1.56M.
AQR Arbitrage first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
AQR Arbitrage's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $1.56M in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on AQR Arbitrage's 13F filing for Q2 2023, filed 14 Aug 2023.